newsfilter
← Latest News
GlobeNewswire·

Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx

Favorable safety and tolerability were observed Primary and multiple secondary endpoints were met with significant reduction in triglyceride levels, additional lipid parameters and ANGPTL3 ...